Yuchuan Gong
20Patents
8h-index
40Co-inventors
71Inventor score
Filing activity: Nov 21, 2011 → Nov 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8410274B2 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 92 | Active |
| US8754224B2 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 76 | Active |
| US9139530B2 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 59 | Active |
| US9670163B2 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 42 | Active |
| US9931334B2 | Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 33 | Active |
| US10537565B2 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 21 | Active |
| US9321765B2 | Crystalline bromodomain inhibitors | Chemistry; Metallurgy | 17 | Active |
| US8722657B2 | Salts and crystalline forms of an apoptosis-inducing agent | Human Necessities | 13 | Active |
| US8962675B1 | Atrasentan mandelate salts | Chemistry; Metallurgy | 8 | Active |
| US9637476B2 | Atrasentan mandelate salts | Chemistry; Metallurgy | 4 | Active |
| US11291662B2 | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Emerging Cross-Sectional Technologies | 4 | Active |
| US9469673B2 | Crystaline forms of HCV inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9238649B2 | Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | Human Necessities | 2 | Active |
| US9840502B2 | Salts and crystalline forms of an apoptosis-inducing agent | Human Necessities | 1 | Active |
| US8598216B1 | Ritonavir bis-hydrochloride | Chemistry; Metallurgy | 1 | Active |
| US11504378B2 | Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same | Human Necessities | 0 | Active |
| US10730873B2 | Salts and crystalline forms of an apoptosis-inducing agent | Human Necessities | 0 | Active |
| US12083227B2 | Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis | Human Necessities | 0 | Active |
| US12220417B2 | Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same | Human Necessities | 0 | Active |
| US9174944B1 | Crystalline lopinavir/surfactant adducts | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.